Growth and nutrition in children with ataxia telangiectasia

Emma Stewart1, Andrew P Prayle2, Alison Tooke1

  • 1Nottingham Children's Hospital, National Paediatric Ataxia Telangiectasia Clinic, QMC, Nottingham, UK.

Insights

Children with Ataxia-Telangiectasia (A-T) experience progressive growth failure. Early consideration of percutaneous endoscopic gastrostomy (PEG) feeding from age 8 may improve nutritional outcomes and prevent decline.

Area of Science:

  • Pediatric Medicine
  • Genetics
  • Nutrition Science

Background:

  • Ataxia-Telangiectasia (A-T) is a rare, severe genetic disorder impacting multiple organ systems.
  • A-T is associated with high early mortality, primarily due to pulmonary complications and cancer.
  • Nutritional status significantly influences outcomes in pediatric respiratory diseases, including A-T.

Purpose of the Study:

  • To investigate the hypothesis of progressive growth failure in children with A-T.
  • To evaluate the efficacy of early percutaneous endoscopic gastrostomy (PEG) feeding as a management strategy.
  • To assess nutritional outcomes in children with A-T.

Main Methods:

  • Prospective data collection on weight, height, and BMI Z-scores at a national A-T clinic.
  • Assessment of oral intake adequacy and safety.
  • Nutritional advice provided during multidisciplinary reviews.

Main Results:

  • 101 children with A-T showed declining weight, height, and BMI Z-scores over time, particularly after age 8.
  • 35% of children had weight Z-scores below -2 on at least one occasion.
  • A trend towards improved weight was observed in the 14% of children who received PEG feeding.

Conclusions:

  • Children with A-T exhibit progressive growth faltering.
  • Understanding the mechanisms of growth failure in A-T is crucial for developing new interventions.
  • Proactive consideration of PEG feeding from age 8 onwards is recommended to mitigate progressive growth failure.
Abstract

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.7K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
986
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1000
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.5K
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
1.4K